ThermoGenesis Holdings (THMO)

ThermoGenesis Holdings (THMO) Stock Price & Analysis


THMO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.03 - $14.40
Previous Close$1.38
Average Volume (3M)54.21K
Market Cap
Enterprise Value$4.93M
Total Cash (Recent Filing)$4.45M
Total Debt (Recent Filing)$7.16M
Price to Earnings (P/E)-0.1
Nov 16, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-12.95
Shares Outstanding2,482,298
10 Day Avg. Volume59,283
30 Day Avg. Volume54,207
Standard Deviation2.80
Financial Highlights & Ratios
Price to Book (P/B)1.92
Price to Sales (P/S)1.51
Price to Cash Flow (P/CF)-1.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.51
Enterprise Value/Gross Profit-0.63
Enterprise Value/Ebitda0.70
Price Target Upside313.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was ThermoGenesis Holdings’s price range in the past 12 months?
ThermoGenesis Holdings lowest stock price was $1.03 and its highest was $14.40 in the past 12 months.
    What is ThermoGenesis Holdings’s market cap?
    Currently, no data Available
    When is ThermoGenesis Holdings’s upcoming earnings report date?
    ThermoGenesis Holdings’s upcoming earnings report date is Nov 16, 2023 which is in 44 days.
      How were ThermoGenesis Holdings’s earnings last quarter?
      ThermoGenesis Holdings released its earnings results on Aug 10, 2023. The company reported -$0.91 earnings per share for the quarter, missing the consensus estimate of $0.01 by -$0.92.
        Is ThermoGenesis Holdings overvalued?
        According to Wall Street analysts ThermoGenesis Holdings’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does ThermoGenesis Holdings pay dividends?
          ThermoGenesis Holdings does not currently pay dividends.
          What is ThermoGenesis Holdings’s EPS estimate?
          ThermoGenesis Holdings’s EPS estimate is -$0.21.
            How many shares outstanding does ThermoGenesis Holdings have?
            ThermoGenesis Holdings has 2,482,298 shares outstanding.
              What happened to ThermoGenesis Holdings’s price movement after its last earnings report?
              ThermoGenesis Holdings reported an EPS of -$0.91 in its last earnings report, missing expectations of $0.01. Following the earnings report the stock price went down -11.594%.
                Which hedge fund is a major shareholder of ThermoGenesis Holdings?
                Currently, no hedge funds are holding shares in THMO


                ThermoGenesis Holdings Stock Smart Score

                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                ThermoGenesis Holdings

                ThermoGenesis Holdings, Inc. engages in the research, development, commercialization and marketing of automated technologies for cell-based therapies for use in regenerative medicine. It operates through the following segments: Device and Clinical Development. The Device segment includes development and commercialization of automated systems that provide good manufacturing practice, clinical grade cell-banking, cell-processing and cell-based therapeutics. The Clinical Development segment develops autologous stem cell-based therapeutics that address significant unmet medical needs for the vascular, cardiology, and orthopedic markets. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.


                Top 5 ETFs holding THMO

                Market Value
                Smart Score
                iShares Core S&P Total U.S. Stock Market ETF
                Up to five ETFs with an Outperform Smart Score that hold THMO. The ETFs are listed according to market value of THMO within the ETF

                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Brainstorm Cell Therapeutics
                Cocrystal Pharma
                NovaBay Pharma

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis